Nuvo Research and Apotex reach PENNSAID patent settlement
31-01-2013
mraoraor / iStockphoto.com
Healthcare firm Nuvo Pharmaceuticals has announced the acquisition of Resultz (isopropyl myristate) from US company Piedmont Pharmaceuticals.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Nuvo Pharmaceuticals, head lice, Resultz, Piedmont Pharmaceuticals, treatment, pharmaceuticals, IP, acquisition
